Our meta-analysis revealed a significant decrease in TGF-β protein levels in vitiligo patients when compared to controls (p = 0.01, SMD: -1.40 [-2.49, -0.30]), Figure 4(b)). The gene discussed is TGFB1; the disease is vitiligo.